The National Institutes of Health has announced the selection of the latest cohort of Lasker Clinical Research Scholars, a joint initiative of the NIH and the Albert and Mary Lasker Foundation that aims to nurture the next generation of outstanding clinical scientists.
Three researchers will receive funding to conduct independent clinical and translational research over five to seven years at the NIH campus in Bethesda, Maryland. Upon review of their projects, they may receive additional financial support from NIH or an NIH-funded research institution. In addition, the scholars will have access to the NIH Clinical Center, the largest hospital in the world devoted to clinical research, while the foundation will provide them with additional support, including travel to scientific meetings and opportunities to participate in selected foundation activities such as the Lasker Awards ceremonies.
The researchers selected to participate in the program are Hans Ackerman, chief of the physiology section in the Sickle Cell Branch at the National Heart, Lung, and Blood Institute; Andrea Apolo, chief of the bladder cancer section at the National Cancer Institute; and Falk Lohoff, chief of the section on clinical genomics and experimental therapeutics in the Laboratory of Clinical and Translational Studies at the National Institute on Alcohol Abuse and Alcoholism.
"The Lasker Clinical Research Scholars is an innovative program that supports accomplished young clinician researchers as they work to discover new knowledge and develop therapies and cures," said Lasker Foundation president Claire Pomeroy. "Providing career pathways for the next generation of scientific investigators is crucial to carrying out the Lasker mission to improve health by accelerating support of medical research. We are excited to continue growing this program and look forward to the breakthroughs that will be made by these talented individuals."